Daryl Rebeck
President
Biotechnology
LexaGene
United States of America
Biography
Mr. Rebeck has over 15 years of capital market experience and an established international financial network. Mr. Rebeck was a Vice President and Senior Investment Advisor with Canada’s largest independent investment bank, Canaccord Genuity, where he was responsible for raising significant risk capital for growth companies, with a particular focus on natural resources and medical technology. Daryl has since worked to provide management expertise and grow shareholder value for the organizations that he has worked with. He recently resigned as Senior VP of Corporate Finance of TSX listed Auryn Resources, a $250 million market cap mining exploration company. Previous to this Mr. Rebeck was also a consultant of corporate finance with Cayden Resources Inc., which was sold to Agnico Eagle Mining Limited for $205 million in November 2014.
Research Interest
LexaGene is a biotechnology company developing a fully automated pathogen detection platform for use at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. LexaGene’s technology aims to transform the way organizations prevent and diagnose disease in multi-billion dollar markets such as food safety, veterinary diagnostics, water quality monitoring, aquaculture pathogen surveillance